1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Global Infectious Disease Rapid Diagnostic Testing Market: Focus on Product, Disease, Technology, Application, End User, Region/Country Data, and Competitive Landscape - Analysis and Forecast, 2020-2025

Global Infectious Disease Rapid Diagnostic Testing Market: Focus on Product, Disease, Technology, Application, End User, Region/Country Data, and Competitive Landscape - Analysis and Forecast, 2020-2025

  • June 2020
  • 217 pages
  • ID: 5914196
  • Format: PDF
  • BIS Research
Up to $1200 off Until Aug 10th 2020


Table of Contents

Global Infectious Disease Rapid Diagnostic Testing Market to Reach $2,853.2 Million by 2025

Market Report Coverage - Infectious Disease Rapid Diagnostic Testing

Market Segmentation

•Product – Infectious Disease Diagnostics Assays and Platforms
•Technology- Real-Time PCR , Isothermal Nucleic Acid Amplification Technology (INAAT), Lateral Flow Immunoassay, Enzyme Immunoassay, and Others
•Disease- Bacterial, Viral, and Others
•Application – Respiratory Infection, Gastro-intestinal Infection, Central Nervous System Infection, sexually transmitted infections, Hospital Acquired Infections and Other Infections
•End User – Hospital, Clinics, Diagnostic Centers, and Other End Users

Regional Segmentation

•North America – U.S., Canada
•Europe – Germany, France, Italy, U.K., Spain, Russia, and Rest-of-Europe
•Asia-Pacific – China, Japan, India, Taiwan, South Korea, Singapore, Australia, and Rest-of-Asia-Pacific (RoAPAC)
•Latin America – Brazil, Mexico, and Rest-of-the-Latin America
•Middle East

Growth Drivers

•Rising Incidence of Frequent Pandemics such as COVID-19 Infectious Disease Inciting the Development of Rapid Diagnostic Assays
•Significant Innovation Resulting in Market Pull
•Shift from Centralized to Decentralized Laboratories
•Significant External Funding for Executing R&D Exercises

Market Challenges

•Lack of Standard Regulatory Processes
•Shortage of Skilled Professionals and Trained Lab Technicians
•Less Efficiency of Rapid Diagnostic Testing as Compared with Laboratory Testing

Market Opportunities

•Development of Infectious Disease Diagnostic Assays for Various Clinical Areas
•Massive Scope for Adoption of Infectious Disease Rapid Diagnostic Testing in Emerging Nations

Key Companies Profiled

Abbott Laboratories, F. Hoffman-La Roche Ltd, Danaher Corporation, Luminex Corporation, BGI Group, bioMérieux S.A., DiaSorin S.p.A, Hologic, Inc., Mesa Biotech, Quidel Corporation, Thermo Fisher Scientific Inc., GenMark Diagnostics, CTK Biotech, Becton, Dickinson and Company, and Cellex Inc.

Key Questions Answered:
• What are the major market drivers, challenges, and opportunities in the global infectious disease rapid diagnostics testing market?
• What are the underlying structures resulting in the emerging trends within the infectious disease diagnostic assays and systems?
• What was the market value of the leading segments of the global infectious disease rapid diagnostics testing market in 2019?
• What are the influencing factors that may affect the market share of the key players?
• How is the industry expected to evolve during the forecast period 2020-2025?
• What are the key developmental strategies which are implemented by the key players to sustain in the competitive market?
• What is the current market share of each of the companies in the global infectious disease rapid diagnostics testing market and what are expected to be their contributions in 2025?
• What is the growth potential of infectious disease diagnostics in each region, including North America, Europe, Asia-Pacific, Latin America, Middle East, Africa and Rest-of-the-World?
• What are the key regulatory implications in developed and developing regions for infectious disease diagnostics?
• What is the expected compound growth rate to be witnessed by the leading players in the market during the forecast period 2020-2025?
• What key strategies have been incorporated by the leading players for furthering the growth of infectious disease industry?
• How is a pandemic such as COVID-19 expected to impact development of rapid diagnostic for infectious disease testing?

Market Overview

Our healthcare experts have found infectious disease industry to be one of the most rapidly evolving markets. The global market for infectious disease rapid diagnostic testing is predicted to grow at a CAGR of 12.36% over the forecast period of 2020-2025. The market is driven by certain factors, which include the rising incidence of frequent pandemics such as COVID-19, infectious diseases inciting the development of rapid diagnostic assays, significant innovation resulting in market pull, shift from centralized to decentralized laboratories, and significant external funding for executing R&D exercises.

The market is favored by the development of rapid diagnostics assays for several clinical areas such as respiratory infections, central nervous system infection, sexually transmitted infection, among others. Recent infectious disease outbreaks such as Zika, Ebola, and COVID- 19 have furthered the growth of the market.

Furthermore, several diagnostic companies are focusing on the development of rapid diagnostics with higher sensitivity and low turn-around time to benefit the patients, providing diagnosis of an infectious disease at the point of care.

Within the research report, the market is segmented on the basis of product type, application, technology, disease end users, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The exponential rise in the application of precision medicine on a global level has created a buzz among companies to invest in the development of rapid diagnostics providing accurate results at a shorter turn-around time. Due to the diverse product portfolio and intense market penetration, Abbott Laboratories has been a pioneer in this field and been a significant competitor in this market.

Several other companies such as F. Hoffman-La Roche Ltd, GenMark Diagnostics Inc., and Bio-Rad Laboratories, among others, have launched diagnostics assays for COVID-19, such as cobas SARS-CoV-2 Test, ePlex SARS-CoV-2 Test, and Fast Track Diagnostics (FTD) SARS-CoV-2 Assay respectively, to compete with ABBOTT REALTIME SARS-COV-2 ASSAY market dominance.

On the basis of region, North America holds the largest share of infectious disease rapid diagnostic testing market due to improved healthcare infrastructure, rise in per capita income, and availability of state-of-the-art research laboratories and institutions in the region. Apart from this, Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period.

Countries Covered
• North America
• U.S
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest-of-Europe
• Asia-Pacific
• China
• Japan
• India
• Taiwan
• South Korea
• Singapore
• Australia
• Rest-of-APAC
• Latin America
• Brazil
• Mexico
• Rest-of-Latin America
• Middle East
• Africa
• Rest-of-the-World (RoW)

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
15% Off


  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on